ACCOUNTS - Final Accounts preparation

Registered number: 10174343

Charity number: 1168013

MEDICINE FOR THE WORLD

(A Company Limited by Guarantee)

UNAUDITED

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

MEDICINE FOR THE WORLD

(A Company Limited by Guarantee)

CONTENTS

	Page
Reference and Administrative Details of the Company, its Trustees and Advisers	1
Trustees' Report	2 - 3
Trustees' Responsibilities Statement	4
Statement of Financial Activities	5
Balance Sheet	6 - 7
Notes to the Financial Statements	8 - 10

MEDICINE FOR THE WORLD

(A Company Limited by Guarantee)

REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS

FOR THE YEAR ENDED 31 MARCH 2026

Trustees	David Simon Levin
	Nicola Abigail Rosenfelder

Company registered number

10174343

Charity registered number

1168013

Registered office

101 New Cavendish Street

1st Floor South

London

W1W 6XH

Accountants

Harris & Trotter LLP

Chartered Accountants

101 New Cavendish Street

1st Floor South

London

W1W 6XH

Page 1

MEDICINE FOR THE WORLD

(A Company Limited by Guarantee)

TRUSTEES' REPORT

FOR THE YEAR ENDED 31 MARCH 2026

The Trustees present their annual report together with the financial statements of the Company for the year ended 31 March 2026. The Annual Report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual Report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).

Since the Company qualifies as small under section 382 of the Companies Act 2006, the Strategic Report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.

Objectives and activities

a. Policies and objectives

The Charity obtain donations of original, unused, in-date medical supplies from the UK which would otherwise be wasted and send them to hospitals and clinics in resource poor locations which have specific needs for them

In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.

Achievements and performance

a. Review of activities

The charity has been inactive this period.

The Trustees are reviewing the best course of action for the future.
During the period under review, Medicine for The World achieved the following financial and operational milestones: Donated funds received - £nil (2025: £nil);
Logistics and technical costs amounted to £nil (2025: £nil);
The closing balance of the bank account for the year was £46 (2025: £46).

b. Fundraising activities and income generation

During the year the Charity did not carry out any fundraising activities.

Page 2

MEDICINE FOR THE WORLD

(A Company Limited by Guarantee)

Financial review

a. Going concern

The Trustees have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.

b. Reserves policy

The balance of undistributed income resources at 31 March 2026 totalled £46. Any undistributed income during the year to be earmarked for direct charitable expenditure in the following year.

c. Financial risk management objectives and policies

The Trustees have assessed the major risks to which the charity is exposed, in particular those related to the operations and finances of the charity, and are satisfied that systems and procedures are in place to mitigate our exposure to the major risks.

Structure, governance and management

a. Constitution

The company is registered as a charitable company limited by guarantee and was set up by a Memorandum of Association on 11 May 2016. The liability of the members is limited to a sum not exceeding £10, being the amount that each member undertakes to contribute to the assets of the charity in the event of its being wound up.

The company is a registered charity number 1168013.

b. Methods of appointment or election of Trustees

The management of the Company is the responsibility of the Trustees who are elected and co-opted under the terms of the Memorandum of Association.

Approved by order of the members of the board of Trustees and signed on their behalf by:

David Simon Levin
Date: 28 July 2026

Page 3

MEDICINE FOR THE WORLD

(A Company Limited by Guarantee)

STATEMENT OF TRUSTEES' RESPONSIBILITIES

FOR THE YEAR ENDED 31 MARCH 2026

The Trustees (who are also the directors of the Company for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial . Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

∙select suitable accounting policies and then apply them consistently;

∙observe the methods and principles of the Charities SORP (FRS 102);

∙make judgments and accounting estimates that are reasonable and prudent;

∙state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;

∙prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Approved by order of the members of the board of Trustees on 28 July 2026 and signed on its behalf by:

David Simon Levin

Page 4

MEDICINE FOR THE WORLD

(A Company Limited by Guarantee)

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT)

FOR THE YEAR ENDED 31 MARCH 2026

	Unrestricted funds 2026	Total funds 2026	Total funds 2025
Note	£	£	£

Income from:
Total income		-	-	-

Expenditure on:
Total expenditure		-	-	-

Net movement in funds

Reconciliation of funds:
Total funds brought forward	46	46	46
Total funds carried forward	46	46	46

The Statement of Financial Activities includes all gains and losses recognised in the year.

The notes on pages 8 to 10 form part of these financial statements.

Page 5

MEDICINE FOR THE WORLD

(A Company Limited by Guarantee)

REGISTERED NUMBER: 10174343

BALANCE SHEET

AS AT 31 MARCH 2026

			2026		2025
	Note		£		£

Current assets
Cash at bank and in hand	46		46
	46		46
Current liabilities
Net current assets		46		46
Total assets less current liabilities		46		46
Net assets excluding pension asset		46		46
Total net assets		46		46

Charity funds
Unrestricted funds	3	46	46
Total funds		46	46

Page 6

MEDICINE FOR THE WORLD

(A Company Limited by Guarantee)

REGISTERED NUMBER: 10174343

BALANCE SHEET (CONTINUED)

AS AT 31 MARCH 2026

The Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

The financial statements were approved and authorised for issue by the Trustees on 28 July 2026 and signed on their behalf by:

................................................ David Simon Levin
The notes on pages 8 to 10 form part of these financial statements.

Page 7

MEDICINE FOR THE WORLD

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

1.Accounting policies

1.1

Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Medicine For The World meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

1.2

Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

2.	Trustees' remuneration and expenses
	During the year, no Trustees received any remuneration or other benefits (2025 - £NIL).

During the year ended 31 March 2026, no Trustee expenses have been incurred (2025 - £NIL).

Page 8

MEDICINE FOR THE WORLD

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

Statement of funds

Statement of funds - current year
	Balance at 1 April 2025 £	Balance at 31 March 2026 £
Unrestricted funds

General Funds - all funds

Statement of funds - prior year
	Balance at 1 April 2024 £	Balance at 31 March 2025 £
Unrestricted funds

General Funds - all funds

Analysis of net assets between funds

Analysis of net assets between funds - current year
	Unrestricted funds 2026	Total funds 2026
	£	£

	Current assets	46	46
	Total	46	46

Page 9

MEDICINE FOR THE WORLD

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

4.Analysis of net assets between funds (continued)

Analysis of net assets between funds - prior year
	Unrestricted funds 2025	Endowment funds 2025	Total funds 2025
	£	£	£

	Current assets	-	46	46
	Total	-	46	46

Page 10